Answers are grounded in this paper and cite their sources.
Background: Major orthopaedic procedures, including total knee replacement (TKR), total hip replacement (THR), and hip fracture surgery, are associated with an increased risk of postoperative venous thromboembolism (VTE). Pharmacological thromboprophylaxis is widely used to reduce the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE), although anticoagulant therapy may be associated with bleeding and wound-related complications. Aim: To evaluate the clinical outcomes of pharmacological VTE prophylaxis among patients undergoing arthroplasty and hip fracture surgery. Materials and Methods: A prospective observational study was conducted in the Department of Orthopaedics, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, from March 2025 to February 2026. A total of 78 patients undergoing TKR, THR, or hip fracture surgery were included after obtaining informed consent. Patients with preoperative VTE, pregnancy, GFR <30 mL/min, cirrhosis, thrombocytopenia, and major pre-existing risk factors for thromboembolism were excluded. All participants received pharmacological prophylaxis with enoxaparin. Patients were followed postoperatively for the development of DVT, PE, bleeding complications, wound hematoma, lower-limb oedema, and mortality. Data were analysed using appropriate descriptive and inferential statistical methods, with p<0.05 considered statistically significant. Results: Among the 78 patients, 66.7% were females and 33.3% were males. Osteoarthritis of the knee was the most common diagnosis (78.2%), followed by NOF fracture (15.4%). Bilateral TKR was performed in 39.7% and unilateral TKR in 38.5% of patients. Cemented arthroplasty was performed in 83.3%, while 16.7% underwent uncemented procedures. All patients received enoxaparin prophylaxis. Wound hematoma and bilateral lower-limb oedema were observed in 3.8% of patients. No proximal or distal DVT was detected. Pulmonary embolism occurred in 1.3% of patients, with the affected patient dying on the fifth postoperative day. Conclusion: Pharmacological VTE prophylaxis with enoxaparin was associated with a low incidence of clinically evident thromboembolic and bleeding complications in patients undergoing major orthopaedic surgery. However, the occurrence of fatal PE despite prophylaxis highlights the need for continued postoperative vigilance and individualized assessment of thromboembolic risk. Larger prospective studies with longer follow-up are required to further establish the effectiveness and safety of pharmacological thromboprophylaxis in orthopaedic patients.
No takes yet. Share an insight, caveat, or question.
Raj et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: